article thumbnail

Galderma & PatientFi Announce a Monthly Membership Program for Custom Galderma Treatment Plans

MedEsthetics

The monthly membership pays for custom treatment plans with Galderma’s portfolio of innovative aesthetic products, all while earning patient loyalty points through Aspire Galderma Rewards.

article thumbnail

Galderma & PatientFi Announce a Monthly Membership Program for Custom Galderma Treatment Pans

MedEsthetics

The monthly membership pays for custom treatment plans with Galderma’s portfolio of innovative aesthetic products, all while earning patient loyalty points through Aspire Galderma Rewards.

article thumbnail

Breaking Business News: Crown Laboratories to Buy Revance Therapeutics in $924 Million Merger Deal

The Dermatology Digest

“Revance has an impressive track record in developing innovative aesthetics offerings that will complement Crown’s innovative line of skincare products. . “Revance has an impressive track record in developing innovative aesthetics offerings that will complement Crown’s innovative line of skincare products.

article thumbnail

Make Every Month Earth Month With Cap Series

Pivot Point International

Embrace the Evolution of a More Sustainable Future In our ever-evolving industry, innovation isn’t just a buzzword—it’s a necessity. As a company deeply committed to sustainability, we’ve embarked on a journey to revolutionize our educational hair portfolio. Our mission? It’s a pledge to do our part for a more sustainable future.

article thumbnail

FDA Approves JUVÉDERM VOLUMA XC for Filling Temple Hollows

The Dermatology Digest

“The approval of JUVÉDERM VOLUMA XC to treat temple hollows further demonstrates Allergan Aesthetics commitment to innovation and addressing patient needs,” says Carrie Strom, President, Allergan Aesthetics and Senior Vice President, AbbVie, in a news release. “This is the first U.S.

article thumbnail

Incyte, CMS Partner to Develop Povorcitinib in Mainland China, Hong Kong, Macau, Taiwan, and Southeast Asia

The Dermatology Digest

“There remains a significant need for new, innovative treatment for vitiligo and other immune-mediated dermatologic conditions, and we look forward to working together with the CMS team to bringing these products to market in China.”

article thumbnail

Dr. Suzan Obagi Named First-ever Chief Medical Director at Obagi Cosmeceuticals

The Dermatology Digest

In her role of Chief Medical Director, Dr. Obagi will help shape Obagi’s product development, portfolio refinement, research initiatives, and educational programs. “I Suzan Obagi, MD, is Obagi Cosmeceuticals LLC’s first-ever Chief Medical Director. Obagi is a subsidiary of Waldencast plc.

Medical 36